HINARI
HINARI Access to Research in Health Programme is a global initiative that enables low- and middle-income countries to gain access to one of the largest collections of biomedical and health literature. Over 15,000 information resources are available to health institutions, universities, and research institutions in more than 120 countries, providing researchers, health professionals, and policy-makers with access to high-quality, timely, and relevant information.
Overview
HINARI was established by the World Health Organization (WHO) in collaboration with major publishers in the health sector in 2002. The initiative is part of the Research4Life programme, which also includes AGORA (Access to Global Online Research in Agriculture), OARE (Online Access to Research in the Environment), ARDI (Access to Research for Development and Innovation), and GOALI (Global Online Access to Legal Information). HINARI's primary goal is to improve the quality of healthcare, education, and research in developing countries by providing access to the latest evidence-based information.
Eligibility and Access
Access to HINARI is based on the gross national income (GNI) per capita of a country. Countries, areas, and territories with a GNI per capita below a certain threshold are eligible for free access, while those with a GNI per capita above the threshold but below a higher threshold are eligible for access at a significantly reduced rate. Eligible institutions must register to participate in the programme, and access is provided to all staff and students.
Content and Resources
HINARI offers access to a wide range of resources, including:
The content covers a broad spectrum of topics in the health and biomedical fields, from basic science to clinical medicine, public health, and more. The resources are provided by leading publishers in the health sciences, including Elsevier, Wiley-Blackwell, Springer, and many others.
Impact and Challenges
HINARI has had a significant impact on healthcare and research in eligible countries. It has improved the quality of research by providing access to up-to-date information, facilitated evidence-based healthcare practices, and supported education and training in the medical and health sciences. However, challenges remain, including ensuring sustainable access to resources, raising awareness of HINARI among potential users, and training users to effectively utilize the available resources.
Future Directions
The future of HINARI involves expanding access to information resources, enhancing the user experience through improved platform technology, and increasing the capacity of local institutions to utilize these resources effectively. Collaboration with publishers, local governments, and international organizations will continue to be crucial in achieving these goals.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD
